Literature DB >> 12441168

The differential expression of corticotropin releasing factor and its binding protein in the gerbil hippocampal complex following seizure.

Seung-Kook Park1, Dong-Il Choi, In-Koo Hwang, Sung-Jin An, Jun-Gyo Suh, Yang-Seok Oh, Moo Ho Won, Tae-Cheon Kang.   

Abstract

Considerable attention has been focused on the role of corticotropin releasing factor (CRF) as well as CRF-binding protein (CRF-BP) in neuropsychiatric disorders and neurodegenerative diseases including epilepsy. Therefore, in the present study, we investigated the temporal and spatial alteration of CRF and CRF-BP in the gerbil hippocampal complex in order to characterize the possible changes and associations with different sequelae of spontaneous seizure in these animals. CRF immunoreactivity was shown in the interneurons of the hippocampal complex at 30 min following seizure. Additionally, alteration of CRF-BP immunoreactivity was restricted to the entorhinal cortex after seizure. These results indicate some factors for consideration. First, in the gerbil hippocampal complex, the delayed increase of CRF immunoreactivity, in spite of its excitatory function, may attenuate seizure activity, but may not do so in epileptogenesis. Second, in contrast to the hippocampal complex, the increase in CRF-BP immunoreactivity in the entorhinal cortex following seizure may participate in feedback inhibitory modulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12441168     DOI: 10.1016/s0197-0186(02)00060-8

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  2 in total

1.  Corticotropin-releasing factor facilitates epileptiform activity in the entorhinal cortex: roles of CRF2 receptors and PKA pathway.

Authors:  Lalitha Kurada; Chuanxiu Yang; Saobo Lei
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

2.  Altered expression of adrenocorticotropic hormone in the epileptic gerbil hippocampus following spontaneous seizure.

Authors:  Yun-Jung Oh; Heung-No Kim; Ji-Heon Jeong; Dae-Kyoon Park; Kyung-Ho Park; Jeong-Sik Ko; Duk-Soo Kim
Journal:  BMB Rep       Date:  2013-02       Impact factor: 4.778

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.